Bio-Techne (TECH) Inventory Average (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Inventory Average of $203.3 million in Q1 2026, little changed quarter-over-quarter from $204.3 million in Q4 2025, and up 7.16% on a YoY basis from $189.7 million in Q1 2025.
Bio-Techne (TECH) Inventory Average (2010 - 2026) Analysis & Trends
Bio-Techne's Inventory Average history runs 17 years deep, the most recent figure standing at $203.3 million for Q1 2026.
- In Q1 2026, Inventory Average rose 7.16% year-over-year to $203.3 million; the TTM figure through Mar 2026 stood at $203.3 million (up 7.16% YoY), while the FY2025 annual figure was $184.6 million, up 5.07% from the prior year.
- Inventory Average was $203.3 million for Q1 2026 at Bio-Techne, roughly flat from $204.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $204.3 million in Q4 2025 to a low of $125.1 million in Q1 2022.
- Historically, Inventory Average has averaged $174.8 million across 5 years, with a median of $180.2 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Inventory Average soared 31.8% in 2023, then gained 1.77% in 2024.
- A 5-year view of Inventory Average shows it stood at $155.1 million in 2022, then rose by 18.27% to $183.5 million in 2023, then gained by 1.77% to $186.7 million in 2024, then climbed by 9.43% to $204.3 million in 2025, then retreated by 0.49% to $203.3 million in 2026.
- The last three Inventory Average figures came in at $203.3 million (Q1 2026), $204.3 million (Q4 2025), and $196.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 203.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.31 Mn |
| Dec 31, 2025 | 204.32 Mn |
| Sep 30, 2025 | 196.32 Mn |
| Jun 30, 2025 | 190.26 Mn |
| Mar 31, 2025 | 189.73 Mn |
| Dec 31, 2024 | 186.71 Mn |
| Sep 30, 2024 | 182.39 Mn |
| Jun 30, 2024 | 179.61 Mn |
| Mar 31, 2024 | 180.17 Mn |
| Dec 31, 2023 | 183.46 Mn |
| Sep 30, 2023 | 178.86 Mn |
| Jun 30, 2023 | 170.55 Mn |
| Mar 31, 2023 | 164.85 Mn |
| Dec 31, 2022 | 155.12 Mn |
| Sep 30, 2022 | 145.57 Mn |
| Jun 30, 2022 | 134.70 Mn |
| Mar 31, 2022 | 125.07 Mn |
| Dec 31, 2021 | 119.61 Mn |
| Sep 30, 2021 | 117.06 Mn |
| Jun 30, 2021 | 113.37 Mn |